GlassScriptPhysician profile
Michael A Brodsky
NPI 1275538423
$119,933.37
in general payments reported to CMS, 2019-2025
24 companies · $3,450 in 2025
The $3,450 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $3,846 · 2021: $19K · 2022: $27K · 2023: $11K · 2024: $35K · 2025: $3,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Food and Beverage: $8,658 · Travel and Lodging: $4,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,015.00 |
| Food and Beverage | $8,657.72 |
| Travel and Lodging | $4,541.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $90,147.21 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16,656.11 | 2023-2025 | Lifevest |
| Biotronik INC. | $3,412.85 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Rivacor 7 Dr-T |
| Abbott Laboratories | $3,193.90 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Boston Scientific Corporation | $1,421.59 | 2019-2025 | Bodyguardian, Patientcare Link, Ingevity Mri |
| Janssen Scientific Affairs, LLC | $890.26 | 2019-2024 | Xarelto |
| Acutus Medical, INC. | $860.71 | 2019 | |
| Philips North America LLC | $585.68 | 2022-2025 | Extended Holter |
| Abiomed | $486.10 | 2023-2025 | Impella |
| Impulse Dynamics (USA) INC. | $485.22 | 2021-2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $364.01 | 2019-2025 | |
| Medtronic, INC. | $308.80 | 2023-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Cvrx, INC. | $211.97 | 2021-2022 | |
| Heartflow, INC. | $165.90 | 2024 | |
| Atricure, INC. | $148.54 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $139.86 | 2021 | |
| Irhythm Technologies, INC. | $131.09 | 2019-2022 | |
| Medtronic Vascular, INC. | $123.54 | 2019 | |
| Alnylam Pharmaceuticals INC. | $118.28 | 2019 | |
| Amgen INC. | $28.80 | 2025 | Repatha |
| Kiniksa Pharmaceuticals International, Plc | $19.27 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $18.82 | 2025 | |
| Tanabe Pharma America, INC. | $14.86 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brodsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.